A randomized controlled trial assessing the effects of the new erythritol air-polishing powder on microbiological and clinical outcomes during supportive periodontal therapy

Not Applicable

• Conditions: K05.3; Chronic periodontitis

• Registration Number: DRKS00005152
• Lead Sponsor: Elektro Medical Systems

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-03-08
• Study Start: 2013-07-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Completion of active treatment for moderate to advanced chronic periodontitis, 2) absence of active periodontal therapy 3 months prior to enrollment, 3) presence of =2 teeth with a minimum of one BoP-positive site with a PPD of =4mm.

Exclusion Criteria

1) any antibiotic therapy within 6 month prior to the study, 2) any indication for an endocarditis prophylaxis, 3) any diagnosis such as chronic bronchitis, asthma or a compromised immune system, and 4) any known hypersensitivity to sugar alcohol (polyol).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of test sites which do bleed after probing with a periodontal probe at baseline and six month after treatment with test or control treatment.<br>

Secondary Outcome Measures

Name	Time	Method
Reduction of probing pocket depth and of the clinical attachment level measured six month after initial treatment with test or control treatment.<br><br>Microbiological differences measured at baseline and six month after treatment by analysis of a microbiological sample taken from study sites.<br><br>Time to treat at baseline to treat study sites by test or control therapy.<br>